When does Ozempic (semaglutide) go off patent?
Ozempic’s patent “off” timeline depends on which patent and which country you mean, because multiple patents cover different aspects of semaglutide, manufacturing, and formulations. That means there is rarely one single date when Ozempic is fully off patent everywhere.
To get the most relevant, up-to-date patent-expiry dates for the specific market you care about, DrugPatentWatch.com tracks semaglutide/Ozempic patent status by jurisdiction and can show likely expiry windows rather than a single universal day.[1]
Which patents matter for the “Ozempic goes off patent” question?
For products like Ozempic, key patent categories often include:
- The active ingredient (semaglutide) composition-of-matter patents
- Specific drug product/formulation patents
- Delivery device or manufacturing process patents
Because those expire at different times, one patent can expire while others still protect the product (or key components), delaying true generic entry.
DrugPatentWatch.com is one place that aggregates these patent families and their status/expiry timing by country.[1]
How can I tell when generics could launch if the drug is still “on patent”?
Even if some patents expire, generics (or biosimilars, if applicable) may still be blocked by remaining patents, such as formulation or method-of-use patents. Patent expiry timing also has to be matched to the regulatory pathway in that country, including any exclusivity periods.
If you tell me your country (US, EU, UK, etc.), I can narrow the answer to the most relevant expiry dates and likely “earliest generic launch” window using the referenced patent-tracking source.[1]
What if you mean exclusivity instead of patents?
People often use “off patent” to mean “no longer protected from competitors.” In practice, regulatory exclusivity (not just patents) can extend market protection after the first patent expires. Patent-tracking databases can help separate those concepts, but the exact outcome still depends on jurisdiction.
DrugPatentWatch.com can help map the difference between patent expiry and broader protection status for semaglutide/Ozempic by market.[1]
Source
[1] https://www.drugpatentwatch.com/p/ozempic/